Cancer Guide Blog: Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Herceptin Given Prior To Surgery Improves The Chance Of Survival Without Relapse For Women With HER2-positive Breast Cancer
http://www.medicalnewstoday.com/articles/132933.php
Standard one year Herceptin treatment provides long-term benefit to patients with high risk of recurrenceAbout 70% of women with locally advanced HER2-positive breast cancer were free of their disease three years after initiation of therapy when treated with Herceptin plus chemotherapy before surgery, compared to only around 50% of patients receiving pre-operative chemotherapy alone.

Wyeth Announces Positive Data From Phase 2 Study Of Neratinib In Advanced HER-2-Positive Breast Cancer
http://www.medicalnewstoday.com/articles/132916.php
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced data from an open-label phase 2 clinical trial of neratinib (HKI-272) in women with advanced HER-2-positive breast cancer. These data suggest that neratinib has antitumor activity in patients with advanced breast cancer positive for the ErbB-2 receptor (also known as HER-2 or Neu).

RAD001 Shows Potential To Reverse Resistance To Herceptin(R) In Metastatic Breast Cancer Patients, Leading To Phase III Trial
http://www.medicalnewstoday.com/articles/132915.php
New data from two early clinical studies show that RAD001(R) (everolimus) may overcome resistance to Herceptin(R) (trastuzumab) in women with HER2-positive metastatic breast cancer. These results support the initiation of a Phase III clinical trial program to fully explore the potential of RAD001 (proposed brand name Afinitor(R)) in breast cancer.

RAD001 Shows Promise In Tough-to-Treat Breast Cancer Patients
http://www.medicalnewstoday.com/articles/132914.php
SAN ANTONIO - Investigators are reporting favorable early results using RAD001 (Afinitor) combined with weekly paclitaxel and trastuzumab to treat patients with HER-2 overexpressing metastatic breast cancer who have demonstrated prior resistance to trastuzumab.

Scholarships For San Antonio Breast Cancer Symposium Awarded To Influential Breast Cancer Advocates
http://www.medicalnewstoday.com/articles/132708.php
The HER2 Support Group, an organization dedicated solely to supporting women with HER2 breast cancer, has announced the recipients of a prestigious scholarship. Along with the Alamo Breast Cancer Foundation (ABCF), the HER2 Support Group selected Heather Gilbert of Lakeforest, California, and Gayla Little of Fair Oaks, Indiana, to attend the ABCF Advocate Program.

----------------------------------------------
** CANCER / ONCOLOGY News **

Good News For Young Male Cancer Patients
http://www.medicalnewstoday.com/articles/132928.php
"Young men undergoing treatment for cancer often want to know how the disease and its treatment affect their chances of fathering healthy children. Our large-scale study shows that there is a slightly higher risk of deformities, but the actual risk of having a child with deformities is nevertheless extremely low.

Potential For Early Cancer Diagnosis Technique
http://www.medicalnewstoday.com/articles/132875.php
A team led by a Northwestern University biomedical engineer has developed a new optical technique that holds promise for minimally invasive screening methods for the early diagnosis of cancer.

Comment By American Heart Association On The International Agency For Research On Cancer, World Cancer Report
http://www.medicalnewstoday.com/articles/132809.php
The International Agency for Research on Cancer (IARC), a division of the World Health Organization (WHO), has released updated cancer death projections in a call to action, asking the government to help fund cancer prevention and research initiatives and international tobacco control policies.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **